Svetlana Glushakova1, Amanda Balaban1, Philip G McQueen2, Rosane Coutinho3, Jeffery L Miller4, Ralph Nossal1, Rick M Fairhurst5, Joshua Zimmerberg1. 1. Program in Physical Biology, Eunice Kennedy Shriver National Institute of Child Health and Development, National Institutes of Health. 2. Mathematical and Statistical Computing Laboratory, Division of Computational Bioscience, Center for Information Technology, National Institutes of Health. 3. Laboratory of Cellular Imaging and Macromolecular Biophysics, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health. 4. Molecular Medicine Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health. 5. Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
Abstract
BACKGROUND: The mechanisms by which α-thalassemia and sickle cell traits confer protection from severe Plasmodium falciparum malaria are not yet fully elucidated. We hypothesized that hemoglobinopathic erythrocytes reduce the intraerythrocytic multiplication of P. falciparum, potentially delaying the development of life-threatening parasite densities until parasite clearing immunity is achieved. METHODS: We developed a novel in vitro assay to quantify the number of merozoites released from an individual schizont, termed the "intraerythrocytic multiplication factor" (IMF). RESULTS: P. falciparum (3D7 line) schizonts produce variable numbers of merozoites in all erythrocyte types tested, with median IMFs of 27, 27, 29, 23, and 23 in control, HbAS, HbSS, and α- and β-thalassemia trait erythrocytes, respectively. IMF correlated strongly (r(2) = 0.97; P < .001) with mean corpuscular hemoglobin concentration, and varied significantly with mean corpuscular volume and hemoglobin content. Reduction of IMFs in thalassemia trait erythrocytes was confirmed using clinical parasite isolates with different IMFs. Mathematical modeling of the effect of IMF on malaria progression indicates that the lower IMF in thalassemia trait erythrocytes limits parasite density and anemia severity over the first 2 weeks of parasite replication. CONCLUSIONS: P. falciparum IMF, a parasite heritable virulence trait, correlates with erythrocyte indices and is reduced in thalassemia trait erythrocytes. Parasite IMF should be examined in other low-indices erythrocytes.
BACKGROUND: The mechanisms by which α-thalassemia and sickle cell traits confer protection from severe Plasmodium falciparummalaria are not yet fully elucidated. We hypothesized that hemoglobinopathic erythrocytes reduce the intraerythrocytic multiplication of P. falciparum, potentially delaying the development of life-threatening parasite densities until parasite clearing immunity is achieved. METHODS: We developed a novel in vitro assay to quantify the number of merozoites released from an individual schizont, termed the "intraerythrocytic multiplication factor" (IMF). RESULTS:P. falciparum (3D7 line) schizonts produce variable numbers of merozoites in all erythrocyte types tested, with median IMFs of 27, 27, 29, 23, and 23 in control, HbAS, HbSS, and α- and β-thalassemia trait erythrocytes, respectively. IMF correlated strongly (r(2) = 0.97; P < .001) with mean corpuscular hemoglobin concentration, and varied significantly with mean corpuscular volume and hemoglobin content. Reduction of IMFs in thalassemia trait erythrocytes was confirmed using clinical parasite isolates with different IMFs. Mathematical modeling of the effect of IMF on malaria progression indicates that the lower IMF in thalassemia trait erythrocytes limits parasite density and anemia severity over the first 2 weeks of parasite replication. CONCLUSIONS:P. falciparum IMF, a parasite heritable virulence trait, correlates with erythrocyte indices and is reduced in thalassemia trait erythrocytes. Parasite IMF should be examined in other low-indices erythrocytes.
Authors: G Lawrence; Q Q Cheng; C Reed; D Taylor; A Stowers; N Cloonan; C Rzepczyk; A Smillie; K Anderson; D Pombo; A Allworth; D Eisen; R Anders; A Saul Journal: Vaccine Date: 2000-03-17 Impact factor: 3.641
Authors: Gregory LaMonte; Nisha Philip; Joseph Reardon; Joshua R Lacsina; William Majoros; Lesley Chapman; Courtney D Thornburg; Marilyn J Telen; Uwe Ohler; Christopher V Nicchitta; Timothy Haystead; Jen-Tsan Chi Journal: Cell Host Microbe Date: 2012-08-16 Impact factor: 21.023
Authors: Edward R Kabyemela; Michal Fried; Jonathan D Kurtis; Theonest K Mutabingwa; Patrick E Duffy Journal: J Infect Dis Date: 2008-07-15 Impact factor: 5.226
Authors: Viola Introini; Alejandro Marin-Menendez; Guilherme Nettesheim; Yen-Chun Lin; Silvia N Kariuki; Adrian L Smith; Letitia Jean; John N Brewin; David C Rees; Pietro Cicuta; Julian C Rayner; Bridget S Penman Journal: Sci Rep Date: 2022-05-27 Impact factor: 4.996
Authors: Nicole Kilian; Sirikamol Srismith; Martin Dittmer; Djeneba Ouermi; Cyrille Bisseye; Jacques Simpore; Marek Cyrklaff; Cecilia P Sanchez; Michael Lanzer Journal: Biol Open Date: 2015-02-20 Impact factor: 2.422
Authors: Matthias Garten; Armiyaw S Nasamu; Jacquin C Niles; Joshua Zimmerberg; Daniel E Goldberg; Josh R Beck Journal: Nat Microbiol Date: 2018-08-27 Impact factor: 17.745